Full metadata record
DC FieldValueLanguage
dc.contributor.authorYang, Yun-Liangen_US
dc.contributor.authorChu, Wen-Lien_US
dc.contributor.authorLin, Chih-Chaoen_US
dc.contributor.authorZhou, Zi-Lien_US
dc.contributor.authorChen, Pei-Ningen_US
dc.contributor.authorLo, Hsiu-Jungen_US
dc.date.accessioned2019-04-02T05:57:58Z-
dc.date.available2019-04-02T05:57:58Z-
dc.date.issued2018-08-01en_US
dc.identifier.issn1369-3786en_US
dc.identifier.urihttp://dx.doi.org/10.1093/mmy/myx094en_US
dc.identifier.urihttp://hdl.handle.net/11536/148128-
dc.description.abstractClinically significant yeast isolates were collected via Taiwan Surveillance of Antimicrobial Resistance of Yeasts (TSARY) in 2014, and mixed infections were investigated. Among 44 out of 1092 specimens containing multiple species, 17, 11, 5, 3, and 8 were from urine, sputum, blood, ascites, and 6 others, respectively. There predominant combinations of mixed infection were 14 Candida albicans/Candida glabrata, 13 C. albicans/Candida tropicalis, and 9 C. glabrata/C. tropicalis. Furthermore, we also detected fluconazole resistant isolates Candida norvegensis and Candida krusei. Hence, it is important to accurately identify the species with different drug susceptibilities when they are in the same specimen.en_US
dc.language.isoen_USen_US
dc.subjectIdentificationen_US
dc.subjectCandida speciesen_US
dc.subjectmixed infectionsen_US
dc.titleMixed yeast infections in Taiwanen_US
dc.typeArticleen_US
dc.identifier.doi10.1093/mmy/myx094en_US
dc.identifier.journalMEDICAL MYCOLOGYen_US
dc.citation.volume56en_US
dc.citation.spage770en_US
dc.citation.epage773en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.department分子醫學與生物工程研究所zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.contributor.departmentInstitute of Molecular Medicine and Bioengineeringen_US
dc.identifier.wosnumberWOS:000444347200012en_US
dc.citation.woscount2en_US
Appears in Collections:Articles